Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Temitope E Adewuyi"'
Autor:
Craig R Ramsay, Temitope E Adewuyi, Joanne Gray, Jenni Hislop, Mark DF Shirley, Shalmini Jayakody, Graeme MacLennan, Cynthia Fraser, Sara MacLennan, Miriam Brazzelli, James N’Dow, Robert Pickard, Clare Robertson, Kieran Rothnie, Stephen P Rushton, Luke Vale, Thomas B Lam
Publikováno v:
Health Technology Assessment, Vol 19, Iss 49 (2015)
Background: For people with localised prostate cancer, active treatments are effective but have significant side effects. Minimally invasive treatments that destroy (or ablate) either the entire gland or the part of the prostate with cancer may be as
Externí odkaz:
https://doaj.org/article/b977a8615ba94caab6a68f19fceb6422
Autor:
Jenni Hislop, Temitope E Adewuyi, Luke D Vale, Kirsten Harrild, Cynthia Fraser, Tara Gurung, Douglas G Altman, Andrew H Briggs, Peter Fayers, Craig R Ramsay, John D Norrie, Ian M Harvey, Brian Buckley, Jonathan A Cook, DELTA group
Publikováno v:
PLoS Medicine, Vol 11, Iss 5, p e1001645 (2014)
BackgroundRandomised controlled trials (RCTs) are widely accepted as the preferred study design for evaluating healthcare interventions. When the sample size is determined, a (target) difference is typically specified that the RCT is designed to dete
Externí odkaz:
https://doaj.org/article/c4ac93096a034f08bf1f2eceeb4c3ae7
Autor:
Jonathan A Cook, Jennifer Hislop, Temitope E Adewuyi, Kirsten Harrild, Douglas G Altman, Craig R Ramsay, Cynthia Fraser, Brian Buckley, Peter Fayers, Ian Harvey, Andrew H Briggs, John D Norrie, Dean Fergusson, Ian Ford, Luke D Vale
Publikováno v:
Health Technology Assessment, Vol 18, Iss 28 (2014)
Background: The randomised controlled trial (RCT) is widely considered to be the gold standard study for comparing the effectiveness of health interventions. Central to the design and validity of a RCT is a calculation of the number of participants n
Externí odkaz:
https://doaj.org/article/b9d9e7adc101402b8c6c2a285b357d4a
Autor:
Eva Compérat, Yuhong Yuan, Suks Minhas, Oliver W. Hakenberg, Nick Watkin, Andrea Necchi, Alberto Coscione, Temitope E Adewuyi, Ekelechi MacPepple, Lorenzo Marconi, Thomas B. Lam, Richard Robinson, Steven MacLennan
Publikováno v:
European urology. 74(1)
Context Management of men with penile squamous cell carcinoma (PSCC) who have high-risk features following radical inguinal lymphadenectomy (ILND) remains controversial. European Association of Urology guidelines state that adjuvant inguinal radiothe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0cdd9078ddcd1460236ae87f019d018
https://pubmed.ncbi.nlm.nih.gov/31532294
https://pubmed.ncbi.nlm.nih.gov/31532294
Autor:
Fiona Stewart, Konstantinos Dimitropoulos, Graeme MacLennan, Temitope E Adewuyi, Oliver W. Hakenberg, Simon Horenblas, Muhammad Imran Omar, Mari Imamura, James N’Dow, T.R. Leyshon Griffiths, Thomas B. Lam, Nick Watkin, Steven MacLennan, Sara MacLennan, Ross Vint, Duncan J. Summerton
Publikováno v:
The Cochrane Library
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of various surgical treatments for localised penile cancer, including oncological efficacy, quality of life and functional impact. (FS: do w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2f45c8c090da1c9247df31de8242b24
https://europepmc.org/articles/PMC6464601/
https://europepmc.org/articles/PMC6464601/
Publikováno v:
BMC Research Notes
Background Randomised controlled trials are widely acknowledged as the gold standard in medical research although their validity can be undermined by non-compliance with the randomly allocated treatment and missing data. Due to the nature of the inte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::08b7e8ae11c9b94656165f3d74a5cc3b
https://pubmed.ncbi.nlm.nih.gov/26336099
https://pubmed.ncbi.nlm.nih.gov/26336099
Autor:
Stephen P Rushton, Kieran Rothnie, Sara MacLennan, Graeme MacLennan, Mark D. F. Shirley, James N'Dow, Temitope E Adewuyi, Cynthia Fraser, Robert Pickard, Joanne Gray, Luke Vale, Clare Robertson, Jenni Hislop, Thomas B. Lam, Craig R Ramsay, Shalmini Jayakody, Miriam Brazzelli
Publikováno v:
Health Technology Assessment, Vol 19, Iss 49 (2015)
© Queen’s Printer and Controller of HMSO 2015.Background People diagnosed with cancer of the prostate, a sex gland in the pelvis, have a choice of treatment options depending on the severity of disease. For people whose cancer is at medium and low
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::151ac24d37215118b02633abcbfcd425
Autor:
Craig R Ramsay, Ian Harvey, Andrew Briggs, John Norrie, Dean Fergusson, Brian S Buckley, Kirsten Harrild, Peter Fayers, Ian Ford, Douglas G. Altman, Jonathan Cook, Jenni Hislop, Cynthia Fraser, Temitope E Adewuyi, Luke Vale
Publikováno v:
Health Technology Assessment, Vol 18, Iss 28 (2014)
BACKGROUND: The randomised controlled trial (RCT) is widely considered to be the gold standard study for comparing the effectiveness of health interventions. Central to the design and validity of a RCT is a calculation of the number of participants n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7fd2bcddb6d8d181bb089010cc9d155
https://pubmed.ncbi.nlm.nih.gov/24806703
https://pubmed.ncbi.nlm.nih.gov/24806703
Autor:
Jenni Hislop, Temitope E Adewuyi, Luke Vale, Peter John Fraser, Kirsten Harrild, Andrew Briggs, John Norrie, Craig R Ramsay, Jonathan Cook, Doug G Altman, Cynthia Fraser, Ian Harvey, Brian S Buckley
Publikováno v:
Trials
Background Determining the sample size is a vital aspect of randomised control trial design; typically a (target) difference is specified. This provides reassurance that the study will be informative; i.e. should such a difference exist, it is likely
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5805c7f7c484370e9bc9b1fb888a92d4
https://doi.org/10.1186/1745-6215-14-s1-o122
https://doi.org/10.1186/1745-6215-14-s1-o122